Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Cell Transplantation|November 2, 2024
Human Stem Cell-Derived Cardiomyocytes Integrate Into the Heart of Monkeys With Right Ventricular Pressure OverloadJodi Scholz, Frank J Secreto, Joan Wobig, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonistXiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityHarry R Chobanian, Yan Guo, Ping Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolismDonald J Marsh, Drew T Weingarth, Dawn E Novi, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of AnemiaPing Liu, Liping Wang, Byron G DuBois, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonistBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Pageof 40